A broad proposal by Medicare to change the way it pays for some drugs has drawn intense reaction and lobbying, with much of the debate centered on whether federal regulators would have too much power over drug prices.
All Stories, New Hampshire Union Leader
Sat, 05/28/2016 - 5:31pm
A broad proposal by Medicare to change the way it pays for some drugs has drawn intense reaction and lobbying, with much of the debate centered on whether federal regulators would have too much power over drug prices.